Company Filing History:
4 out of 291 
2 out of 1,935 
Years Active: 2012-2025
Title: Mokenge P Malafa: Innovator in Pancreatic Cancer Research
Introduction
Mokenge P Malafa is a prominent inventor based in Tampa, FL (US), known for his significant contributions to the field of pancreatic cancer research. With a total of 6 patents, he has developed innovative methods and tools aimed at improving the detection and management of pancreatic cancer.
Latest Patents
One of his latest patents is titled "Microrna assay for detection and management of pancreatic cancer precursors." This invention focuses on miRNAs that are differentially expressed in samples from individuals with pancreatic cancer or those at high risk of developing the disease. The miRNAs serve as biomarkers for diagnosis, treatment, and prevention, particularly in patients with pancreatic lesions. Another notable patent is "Theranostic tools for management of pancreatic cancer and its precursors." This invention involves materials and methods for identifying and classifying pancreatic ductal adenocarcinoma (PDAC) precursors using various biological markers and radiologic measures, facilitating personalized care for patients.
Career Highlights
Mokenge P Malafa has worked with esteemed institutions such as the H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida. His work has significantly advanced the understanding and management of pancreatic cancer.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Jennifer Permuth and Dung-Tsa Chen, contributing to the collective effort in cancer research and innovation.
Conclusion
Mokenge P Malafa's innovative work in pancreatic cancer research exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in cancer detection and treatment.